Track topics on Twitter Track topics that are important to you
Hong Kong, Hong Kong S.A.R., July 04, 2017 --(PR.com)-- The ChinaCare Group announced today that it has been engaged by Shanghai-based Hailong Investment Co Ltd to assist the firm in its expansion and acquisition activities. In this engagement, The ChinaCareGroup will provide due diligence and feasibility assessments of potential acquisitions under consideration by Hailong.
In announcing the engagement, The ChinaCare Group’s senior partner David Wood said, “For the past fourteen years, ChinaCare has been assisting clients in their efforts to introduce new healthcare projects in China. In this engagement CCG will be applying its considerable knowledge and expertise in the Chinese healthcare marketplace to assist Hailong in its investment strategy.” For additional information please consult the company’s website: www.chinacaregroup.com
The ChinaCareGroup has been in existence since 2003 providing consulting, development and management services to the healthcare marketplace in China and Southeast Asia.
Contact via Email
Read the full story here: http://www.pr.com/press-release/722247
Press Release Distributed by PR.com
Original Article: The ChinaCare Group Announces Engagement with Hailong Investment Co LtdNEXT ARTICLE
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...